Preclinical data in SCLC cell lines revealed the presence of a rare sub-clone with a stem-cell phenotype characterized by surface receptor expression of CD44, CD133, multi-drug resistance gene (MDR1) and urokinase plasminogen activator receptor (uPAR) [6–8]. The gene discussed is PLAUR; the disease is small cell lung carcinoma.